journal article·2021-03

Nitric Oxide generating coating alters hematoma structure and soft tissue healing

Jayanti Mendhi, Indira Prasadam, Sugarniya Subramaniam, Long Bai, Weidong Gao, Jyotsna Batra, Ross Crawford, Ying Yang, Yin Xiao

Publisher page

Abstract

Introduction: Peri-implantitis remains a major clinical problem due to the challenges in soft tissue integration on implants surfaces. During tissue healing processes, hematoma formation is the initial response to implant surfaces, which serves as a reservoir for growth factors and provides a natural scaffold for cell infiltration. However, little information is available regarding whether altering hematoma properties can benefit soft tissue healing and tissue integration. This study aims to modulate hematoma properties to create a friendly microenvironment for a strong soft tissue seal on implant surfaces. Methods: We developed a polydopamine (PDAM) based coating capable of well-controlled nitric oxide (NO) generation by applying the copper (Cu) dose gradient. The incorporated copper with progressive raw concentrations of 10, 50 and 250µg/mL in the coating (PDAM@Cu coatings) served as a catalyst and reacted with endogenous NO donors in the blood. The resulting influence on clot structure and tissue healing microenvironment were analyzed along with its impact on the migration and proliferation of human gingival fibroblasts (HGFs). Results: It was noted that NO generation rates could be controlled using Cu from the coatings as a catalyst. As a result of this, the clot formation, structural properties, clot degradation, and growth factor release could be manipulated. Consequently, the NO generating surfaces of PDAM@Cu coating yielded a desired porous structure in clots and growth factor release profile, especially of platelet derived growth factors such as platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF). The NO generating surfaces of PDAM@Cu coating subsequently allowed increased migration and proliferation of HGFs. Conclusion: In this study, we developed a novel NO-generating strategy to regulate hematoma properties and growth factors release. The optimized coating could provide a favourable micro-environment for soft tissue healing and prompt cell migration and proliferation of HGFs. Therefore, PDAM surface modification with incorporation of Cu as a catalyst for NO generation could induce a functional implant surface for soft tissue integration.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Oral and gingival health research · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (83)

Show source-provided references
1. Osseointegrated Dental Implants
2. Osseointegration10.4103/0975-7406.155917 ↗
3. Osseointegration and current interpretations of the bone-implant interface10.1016/j.actbio.2018.11.018 ↗
4. Osseointegrated dental implants: Preliminary report on a replication study10.1016/0022-3913(83)90029-X ↗
5. Evaluation of a novel oral mucosa in vitro implantation model for analysis of molecular interactions with dental abutment surfaces10.1111/cid.12750 ↗
6. Biology of soft tissue repair: Gingival epithelium in wound healing and attachment to the tooth and abutment surface10.22203/eCM.v038a06 ↗
7. Gingival response to dental implant: comparison study on the effects of new nanopored laser-treated vs. traditional healing abutments10.3390/ijms21176056 ↗
8. Zirconia implants with improved attachment to the gingival tissue10.1002/JPER.19-0323 ↗
9. Health, maintenance, and recovery of soft tissues around implants10.1111/cid.12343 ↗
10. Temporal sequence of hard and soft tissue healing around titanium dental implants10.1111/prd.12054 ↗
11. Newman · 2014
12. Human early fracture hematoma is characterized by inflammation and hypoxia10.1007/s11999-011-1865-3 ↗
13. The effect of material characteristics, of surface topography and of implant components and connections on soft tissue integration: a literature review10.1111/j.1600-0501.2006.01367.x ↗
14. Fibrin structure and wound healing10.1111/j.1538-7836.2006.01861.x ↗
15. Alteration of clot architecture using bone substitute biomaterials (beta-tricalcium phosphate) significantly delays the early bone healing process10.1039/C8TB01747F ↗
16. Formation of blood clot on biomaterial implants influences bone healing10.1089/ten.teb.2013.0709 ↗
17. Alteration of blood clot structures by interleukin-1 beta in association with bone defects healing10.1038/srep35645 ↗
18. Influence of interleukin-1 beta on platelet-poor plasma clot formation: a potential impact on early bone healing10.1371/journal.pone.0149775 ↗
19. Biology of wound healing10.1034/j.1600-0757.2000.2220104.x ↗
20. Nitric oxide: physiology, pathophysiology, and pharmacology10.1016/S0031-6997(25)06663-3 ↗
21. Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitis10.1016/j.ijpharm.2014.06.051 ↗
22. Mussel-inspired polydopamine for bio-surface functionalization10.1016/j.bsbt.2016.11.001 ↗
23. Mussel-inspired surface chemistry for multifunctional coatings10.1126/science.1147241 ↗
24. Blood clot formed on rough titanium surface induces early cell recruitment10.1111/clr.12672 ↗
25. Mussel-inspired surface chemistry for multifunctional coatings10.1126/science.1147241 ↗
26. Corrosion control of copper in nitric acid solutions using some amino acids – A combined experimental and theoretical study10.1016/j.corsci.2010.05.039 ↗
27. Nitric oxide release: Part III. Measurement and reporting10.1039/c2cs15271a ↗
28. Nitric oxide based strategies for applications of biomedical devices10.1016/j.bsbt.2015.08.003 ↗
29. Nanoscratch test—A tool for evaluation of cohesive and adhesive properties of thin films and coatings
30. Analyzing fibrin clot structure using a microplate reader10.1097/00001721-200209000-00008 ↗
31. Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency10.1182/bloodadvances.2017015123 ↗
32. Cell-Free DNA modulates clot structure and impairs fibrinolysis in sepsis10.1161/ATVBAHA.115.306035 ↗
33. Blood prefabricated hydroxyapatite/tricalcium phosphate induces ectopic vascularized bone formation via modulating the osteoimmune environment10.1039/C8BM00287H ↗
34. Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material10.4047/jap.2010.2.1.7 ↗
35. Surface modification of zirconia with polydopamine to enhance fibroblast response and decrease bacterial activity in vitro: a potential technique for soft tissue engineering applications10.1016/j.colsurfb.2015.06.047 ↗
36. Factors affecting soft tissue around dental implants: A review of the literature10.1016/j.prosdent.2005.08.021 ↗
37. Soft tissue wound healing around teeth and dental implants10.1111/jcpe.12206 ↗
38. Spontaneous catalytic generation of nitric oxide from S-nitrosothiols at the surface of polymer films doped with lipophilic copper (II) complex10.1021/ja035775x ↗
39. Polyurethane with tethered copper (II)–cyclen complex: preparation, characterization and catalytic generation of nitric oxide from S-nitrosothiols10.1016/j.biomaterials.2008.02.004 ↗
40. Improving blood compatibility of intravascular oxygen sensors via catalytic decomposition of S-nitrosothiols to generate nitric oxide in situ10.1016/j.snb.2006.09.025 ↗
41. Metal organic frameworks as nitric oxide catalysts10.1021/ja210771m ↗
42. S-nitrosothiols in the blood: roles, amounts, and methods of analysis
43. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase10.1073/pnas.95.9.4888 ↗
44. One-step multipurpose surface functionalization by adhesive catecholamine10.1002/adfm.201200177 ↗
45. Nitric oxide release: Part I. Macromolecular scaffolds10.1039/c2cs15272j ↗
46. Copper and genomic stability in mammals10.1016/S0027-5107(01)00076-8 ↗
47. Cytotoxicity of copper ions released from metal10.1385/BTER:102:1-3:129 ↗
48. Nitric oxide metabolism and breakdown10.1016/S0005-2728(99)00020-1 ↗
49. Effective diffusion distance of nitric oxide in the microcirculation10.1152/ajpheart.1998.274.5.H1705 ↗
50. Poly (norepinephrine): Ultrasmooth Material-Independent Surface Chemistry and Nanodepot for Nitric Oxide10.1002/anie.201301646 ↗
51. State of the art, challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications10.1016/j.biotechadv.2015.01.005 ↗
52. An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH10.1111/jth.14002 ↗
53. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency10.1111/jth.12600 ↗
54. Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death10.1016/j.trsl.2019.08.009 ↗
55. Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus
56. A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis10.1126/scitranslmed.3010383 ↗
57. Fibrin clot formation under diverse clotting conditions: Comparing turbidimetry and thromboelastography10.1016/j.thromres.2020.01.001 ↗
58. In vitro blood compatibility of modified PDMS surfaces as superhydrophobic and superhydrophilic materials10.1002/app.13355 ↗
59. Correlation between blood compatibility and physical surface properties of titanium-based coatings10.1016/j.surfcoat.2005.02.093 ↗
60. Surface energy, wettability, and blood compatibility phosphorus doped diamond-like carbon films10.1016/j.diamond.2004.07.019 ↗
61. Facile surface modification of silicone rubber with zwitterionic polymers for improving blood compatibility10.1016/j.msec.2013.05.025 ↗
62. Fibrin concentration affects ACL fibroblast proliferation and collagen synthesis10.1016/j.knee.2009.12.008 ↗
63. Synergistic interactions of blood-borne immune cells, fibroblasts and extracellular matrix drive repair in an in vitro peri-implant wound healing model
64. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure10.1089/ten.2006.12.1587 ↗
65. In vitro preparation and ellipsometric characterization of thin blood plasma clot films on silicon10.1016/S0142-9612(00)00359-8 ↗
66. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte-and platelet-rich fibrin (L-PRF)10.2174/138920112800624382 ↗
67. Three-dimensional structure and cytokine distribution of platelet-rich fibrin10.6061/clinics/2017(02)09 ↗
68. Recent insights into the actions of IGFBP-610.1007/s12079-015-0288-4 ↗
69. IGF-binding proteins: why do they exist and why are there so many?10.3389/fendo.2018.00117 ↗
70. Induction of human fibroblast proliferation by epidermal growth factor (EGF): enhancement by an EGF-binding arginine esterase and by ascorbate10.1073/pnas.73.1.183 ↗
71. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways10.1002/jcp.21041 ↗
72. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity10.1002/(SICI)1097-4652(199812)177:3<439::AID-JCP7>3.0.CO;2-2 ↗
73. Dose controlled nitric oxide-based strategies for antibacterial property in biomedical devices
74. Nitric oxide at a low concentration protects murine macrophage RAW264 cells against nitric oxide-induced death via cGMP signaling pathway10.1038/sj.bjp.0705206 ↗
75. Antibacterial activity and cytocompatibility of chitooligosaccharide-modified polyurethane membrane via polydopamine adhesive layer10.1016/j.carbpol.2016.09.036 ↗
76. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function10.4049/jimmunol.158.5.2375 ↗
77. The role of nitric oxide in innate immunity10.1034/j.1600-065X.2000.917307.x ↗
78. The role of nitric oxide in inflammatory reactions10.1111/j.1574-695X.2007.00329.x ↗
79. Nitric oxide and cell proliferation10.1111/j.1742-4658.2006.05250.x ↗
80. Growth factors in skin wound healing
81. P-423: Effects of TGF–[beta] 1 and PDGF on collagen synthesis of cardiac fibroblasts from spontaneously hypertensive rats10.1016/S0895-7061(01)01581-3 ↗
82. Biofunctionalization of zirconia with cell-adhesion peptides via polydopamine crosslinking for soft tissue engineering: effects on the biological behaviors of human gingival fibroblasts and oral bacteria10.1039/C9RA08575K ↗
83. Surface modification of zirconia with polydopamine to enhance fibroblast response and decrease bacterial activity in vitro: A potential technique for soft tissue engineering applications10.1016/j.colsurfb.2015.06.047 ↗